ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - palbociclib - קפסולות - palbociclib 100 mg - palbociclib

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - palbociclib - קפסולות - palbociclib 125 mg - palbociclib

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - palbociclib - קפסולות - palbociclib 75 mg - palbociclib

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - palbociclib - טבליות מצופות פילם - palbociclib 100 mg - palbociclib

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - palbociclib - טבליות מצופות פילם - palbociclib 125 mg - palbociclib

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - palbociclib - טבליות מצופות פילם - palbociclib 75 mg - palbociclib

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - טבליות מצופות פילם - eletriptan hydrobromide 24.242 mg - eletriptan

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - טבליות מצופות פילם - eletriptan hydrobromide 48.485 mg - eletriptan

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - טבליות מצופות פילם - eletriptan hydrobromide 96.97 mg - eletriptan